Treatment of disorders secondary to organic impairments

Details for Australian Patent Application No. 2002258820 (hide)

International Classifications

Event Publications

8 May 2003 Application Open to Public Inspection

Published as AU-B-2002258820

4 December 2003 Assignment before Grant

Mueller, Peter Sterling The application has been assigned to Snowden Pharmaceuticals, LLC

16 March 2006 Application Accepted

Published as AU-B-2002258820

13 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.